Crispr Therapeutics shares owned by AE Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by AE Wealth Management
from 13F filings
Historical chart of AE Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by AE Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by AE Wealth Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $726k | 12k | 61.00 |
2023-09-30 | $244k | 5.4k | 45.39 |
2023-06-30 | $402k | 7.2k | 56.14 |
2023-03-31 | $207k | 4.6k | 45.23 |
2022-09-30 | $314k | 4.8k | 65.28 |
2022-06-30 | $325k | 5.3k | 60.78 |
2022-03-31 | $260k | 4.1k | 62.77 |
2021-12-31 | $414k | 5.5k | 75.75 |
2021-09-30 | $773k | 6.9k | 111.88 |
2021-06-30 | $804k | 5.0k | 161.90 |
2021-03-31 | $596k | 4.9k | 121.88 |
2020-12-31 | $2.2M | 15k | 153.12 |
2020-09-30 | $938k | 11k | 83.60 |
2020-03-31 | $213k | 5.0k | 42.47 |